Genetically-modified babies are "highly desirable" to help protect people from disease and could be created ethically within two years, according to a new scientific paper.
A freezer malfunctioned at the Children's Hospital Los Angeles, destroying stored blood stem cells for 56 patients, some of whom are fighting cancer.
More women should be assessed for harmful mutations in the BRCA1 and BRCA2 genes that can increase risk of certain cancers, according to new recommendations.
The maker of a gene therapy for babies did not inform federal regulators about
Floating disembodied conscious brains that issue commands to luckless human minions may be a cliché of science fiction, but they are a far cry from the primitive, lab-grown "cerebral organoids" that real scientists study today. New research suggests that contemporary mini-brains -- even if inferior to their fictional counterparts -- are still capable of a surprise or two.
The US Food and Drug Administration approved a treatment Friday for a genetic disease called spinal muscular atrophy that causes infants' muscles to waste away, potentially killing them before age 2.
An experimental stem cell therapy proved effective and safe in patients with a relapsing form of multiple sclerosis (MS), an autoimmune disease that affects the central nervous system, new research finds.
Every baby born in the United States is given a routine blood test to screen for dozens of inherited medical conditions. Now, the U.S. National Institutes of Health is exploring whether to use DNA sequencing to screen newborn babies for additional genetic abnormalities and disorders. Such DNA testing would likely complement, but not replace, the current routine blood tests.
Twelve people in three states developed infections and were hospitalized after they got infusions or injections of stem cell products derived from umbilical cord blood that were contaminated with bacteria, according to a report published Thursday by the US Centers for Disease Control and Prevention.
The current guidelines for genetic testing of breast cancer patients limit the number of women who can get tested. Because of these restrictions, these tests miss as many patients with hereditary cancers as they find, according to a study published Monday in the Journal of Clinical Oncology.